i-Base home
Search Menu
  • Home
  • HTB
  • 2023
  • September

September 2023

Contents

Editorial

  • HTB September 2023
  • Non-technical summary of articles in HTB September 2023

Conference reports

  • 12th IAS Conference on HIV Science (IAS 2023): further reports
  • IAS 2023: Update to navigating the programme and online access
  • IAS 2023: Metabolic and weight changes using GLP-1 agonists in people living with HIV: need for more data
  • IAS 2023: CHAPAS-4 supports better second-line options for children
  • IAS 2023: Rapporteur summary Track A – basic science
  • IAS 2023: Rapporteur summary Track C – prevention
  • IAS 2023: Rapporteur summary Track D – social and behavioural science

Pathogenesis

  • Defective HIV proviral particles linked to persistent inflammation and immune activation despite effective ART
  • Cannabis does not reduce T cells in people living with HIV

mpox

  • Tecovirimat resistance in a person with advanced HIV and delayed ART

Coinfections and complications

  • Timing of ART with cryptococcus: Europe and the US cohort data challenged by African RCT data and editorial comment
  • Peripheral inflammation linked to structural brain changes and reduced blood flow despite suppressive ART

PDFs

  • HTB: no. 9 (Sept 2023) PDF download
  • HTB RSS

Early access

  • TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel 6 June 2025
  • Gates Foundation commits to providing lenacapavir as PrEP next year 3 June 2025
  • All early access reports

Current issues

  • June 2025
  • May 2025
  • April 2025
  • Back issues

Special report

  • Latest news on the US crisis and its impact on global health 1 June 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook